Proven track record with IMP and device studies
We have many years of experience in working with infertility, women’s health, and endocrinology, particularly with various female and male infertility conditions including studies in IVF. We have worked with hGH in the IVF setting (and in the traditional non-infertility setting) and other rarer conditions such as isolated hypogonadotrophic hypogonadism (IHH).
Illingworth conducted a randomised, controlled trial funded by the Department of Health which was the largest intervention study of its kind in Europe, testing the effectiveness of the Family Nurse Partnership (FNP) within the three domains: pregnancy and birth, child health and development, and parental life course and self-sufficiency, versus ordinary maternity services in England.
Illingworth was selected by a world leading Global Diagnostics company to enrol 920 female volunteers to test a new, rapid, pregnancy test. This comprised of a minimum of 300 pregnant ladies. The home research nurse team set up and ran pop-up clinics throughout the study and the data was monitored by Illingworth CRAs. After highly successful study completed in 2.5 months, the study closed, fully recruited, the data was 100% SDV’d and the product was approved for use and on the market 2 months later.